Month: August 2021

Berkeley Lights and Bayer announce a multi-year agreement aimed at revolutionizing the discovery of next-generation traits

Written by Customer Service on August 11, 2021. Posted in Public Companies.

Agreement debuts Berkeley Lights’ rapid high-throughput functional screening capability to accelerate and expand the discovery and development of Bayer Crop Science’s seeds and traits product pipeline EMERYVILLE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI) a leader in the functional characterization of live biology, announced a multi-year agreement with Bayer to develop and perform high-throughput functional screening workflows aimed at accelerating and expanding the discovery of novel traits. Terms of the agreement were not disclosed. Berkeley Lights will leverage its platform to screen individual variants of bioactives for Bayer in a massively high-throughput manner. The outcome will be a significant acceleration of the agricultural leader’s pipeline for discovery and development of novel traits....

Inozyme Pharma Reports Q2 2021 Financial Results and Provides Business Highlights

Written by Customer Service on August 11, 2021. Posted in Public Companies.

– Received Orphan Drug Designation from the European Medicines Agency for INZ-701 for the treatment of ABCC6 Deficiency – – Clinical Trial Application in Europe accepted for Phase 1/2 trial of INZ-701 in ABCC6 Deficiency – – Investigational New Drug application in U.S. accepted for Phase 1/2 trial of INZ-701 in ABCC6 Deficiency – – Expect to enroll patients in Phase 1/2 clinical trials in ENPP1 Deficiency and ABCC6 Deficiency in Q4 2021 and report preliminary biomarker and safety data in the first half of 2022 – – Cash, cash equivalents, and investments expected to support continued operations into the fourth quarter of 2022 – BOSTON, Aug. 11, 2021 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization,...

Barnwell Fiscal Q3 Revenue Increases 28% in the quarterly period to $5.1 Million, Reports Net Earnings of $5.0 Million and $0.59 Net EPS; Regains Compliance with NYSE

Written by Customer Service on August 11, 2021. Posted in Public Companies.

Strong financial results demonstrate significant improvements and turnaround of the company HONOLULU, Aug. 11, 2021 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) today reported results for the three and nine-months ended June 30, 2021. HighlightsQ3 Revenue increased 28% in the quarterly period to $5.1 million Q3 Net earnings were $5.0 million, compared to a net loss of $3.5 million Q3 Net earnings per share was $0.59, compared to a $0.42 net loss per share Nine-month net earnings was $4.7 million, compared to a loss of $5.4 million Nine-month net earnings per share was $0.57, compared to a $0.65 net loss per shareMr. Alexander Kinzler, Chief Executive Officer of Barnwell, commented, “Our significantly improved results for this quarter as compared to the prior year quarter were due primarily to a $4,227,000...

Atotech Reports Second Quarter 2021 Results and Raises 2021 Full Year Guidance

Written by Customer Service on August 11, 2021. Posted in Mergers And Acquisitions.

Generates second quarter revenue of $377 million, an increase of 44% over the prior year period, including chemistry organic revenue growth of 24% Reports net income of $30 million, compared to a net loss of $283 million in Q2 2020, the latter caused by Covid-19 pandemic-related impairment charges Delivers a record Adjusted EBITDA of $118 million, a 63% increase over the prior year period Reduces net leverage to 3.2x Raises guidance for full year 2021 organic revenue growth, which is now expected to be in the range of 13% to 14%, including full year chemistry organic revenue growth of approximately 10% Increases guidance for full year 2021 Adjusted EBITDA1, which is now anticipated to be in the range of $435 million to $450 million, an increase of $18 million over the prior guidance at the mid-pointBERLIN, Aug. 11, 2021 (GLOBE NEWSWIRE)...

Research 2021, Adhesive Bandages Market Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast

Written by Customer Service on August 11, 2021. Posted in Mergers And Acquisitions.

Key Companies Covered in the Adhesive Bandages Market Research Report are Johnson & Johnson Services, Inc., Beiersdorf AG, 3M, Goldwin Medicare, Aso LLC, Precision Coatings Pvt Ltd, L&R USA INC., ConvaTec Inc., Medline Industries, Inc., Elkem ASA and Others. Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) — Increasing prevalence of chronic wounds, accidents and burns is a key factor driving the global adhesive bandages market, says Fortune Business Insights in a report, titled “Adhesive Bandages Market Size, Share and Global Trend by Product (Medicated Bandages, Non- Medicated Bandages), By Material (Fabric, Plastic, Latex), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026.” Adhesive bandages are likely to witness huge demand due to its composition as...

Report 2021, Cranial Implants Market Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Analysis

Written by Customer Service on August 11, 2021. Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Cranial Implants Market Research Report Are Stryker, Zimmer Biomet, Braun Melsungen AG, Medtronic, DePuy Synthes, OsteoMed, Medartis Holding AG,3di GmbH,Xilloc Medical B.V., Cousin Biotech, KLS Martin Group, Bioplate, Inc., Synimed Synergie Ingenierie Medicale SARL Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) — The global cranial implants market will derive growth from advancements in the materials and equipment associated with the procedure. According to a report by Fortune Business Insights, titled “Cranial Implants Market Size, Share & Industry Analysis, By Material (Polymer, Ceramic, Metal), By Type (Customized Cranial Implants, Non-customized Cranial Implants), By End-user (Hospital & Trauma Centres Ambulatory Surgical Centers, Speciality clinics, Others) and Regional Forecast,...

Eye Supplements Market Research Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Analysis

Written by Customer Service on August 11, 2021. Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Eye Supplements Market are Nature’s Bounty Co., Amway Corp., Butterflies Healthcare Ltd, Valeant Pharmaceuticals International Inc., Novartis AG, Bausch & Lomb Incorporated, Akorn Incorporated, Alliance Pharma, Pfizer Inc., Vitabiotics Ltd, and others Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) — The increasing need for maintaining healthy 6/6 eyesight has propelled the demand for “eye supplements” in the market. Rising awareness about eye diseases is a major factor boosting the global eye supplements market, says Fortune Business Insights in their new study. The study is titled,” Eye Supplements Market Size, Share and Global Trend by Product Type (Antioxidants, Fatty Acids, Anti-inflammatory Supplements, Neuro-protective supplements), By Form (Liquid, Gels, Capsule, Tablet), By Application...

Friendable Unveils New Artist and Fan Video Trailers as the Company Prepares Its Digital Marketing Campaign for Kickoff

Written by Customer Service on August 11, 2021. Posted in Public Companies.

CAMPBELL, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Friendable Inc. (OTC: FDBL), a mobile technology and marketing company, is pleased to announce its two new video trailers, designed to showcase the Fan Pass Livestream platform and entice both artists and music fans around the world to sign up and join. View the Artist and Fan videos, along with campaign landing pages at: Artist Video Fan Video “Now that we have successfully released version 2.0 of our Fan Pass platform, along with updating all brand messaging and websites, our focus has turned toward our digital media assets and delivering a campaign that converts to downloads, artist registrations, merchandise sales and fan subscriptions. As with everything marketing related, these assets will be tested and tweaked as media dollars are spent, tracked...

INTERIM REPORT OF COPENHAGEN AIRPORTS A/S (CPH) FOR THE PERIOD 1 JANUARY – 30 JUNE 2021

Written by Customer Service on August 11, 2021. Posted in Public Companies.

Stock Exchange Announcement Copenhagen, 11 August 2021 The Board of Directors has today approved the interim report for the period 1 January – 30 June 2021. SUMMARY OF THE FIRST HALF OF 2021 Serving just 1.4 million passengers in the first half of 2021, a mere fraction of the H1 2019 figure of 14.4 million, Copenhagen Airports incurred a loss before tax of DKK 851 million for the period. After winter and spring seasons with aviation travel heavily restricted and a loss of 90–95% of traffic, prospects began to brighten towards the end of the first half with early signs of passenger growth. In June, the decline in passenger numbers were a little lower at 82.6% relative to 2019, the last year of pre-pandemic normality. CPH remains severely affected by the crisis, and operating costs continue to exceed income. Although passengers are slowly...

Global Cardiac Mapping Systems Market Report 2021-2028 | Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Analysis

Written by Customer Service on August 11, 2021. Posted in Mergers And Acquisitions.

Top Players Covered in the Cardiac Mapping Systems Market Research Report are Medtronic, Abbott, EP Solutions, Biosense Webster, Siemens Healthineers, Boston Scientific, Lepu Medical Technology (Beijing) Co., Ltd. and other key market players Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) — The rise in geriatric population and their susceptibility towards various health issues such as cardiac problems are driving the global cardiac mapping systems market, says Fortune Business Insights in their recent study. The study is titled, “Cardiac Mapping Systems Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” Fortune Business Insights finds the Arrhythmia segment to show high growth in the market. This is owing to the higher prevalence of arrhythmia around the world. The market, as per study will offer lucrative growth...

Month: August 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals